Nifty Midcap 100 News and Updates

Name: Latest research reports of Mankind Pharma Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Mankind Pharma Ltd.
Rating: 4
Author: Geojit BNP Paribas

Keep track of all breaking news on Nifty Midcap 100 from all sources in a single place.

Coforge Ltd.

16 Jun 2026, 09:17PM

1464.80

4.44%

Coforge targets $5 billion revenue by 2030 on AI, deals and acquisitions

Business Standard

The mid-tier IT firm plans to drive growth through large deals, AI investments, acquisitions and expansion in healthcare, public-sector and GCC businesses

Number of FII/FPI investors decreased from 622 to 536 in Mar 2026 qtr

Biocon Ltd.

16 Jun 2026, 02:05PM

416.45

0.10%

Biocon aims to become world's top insulin supplier in five years

Business Line

Chairperson Kiran Mazumdar-Shaw sees opportunity as global pharma giants pivot to GLP-1 therapies.

Biocon Ltd. has an average target of 398.80 from 5 brokers.

Suzlon Energy Ltd.

16 Jun 2026, 01:49PM

57.92

4.23%

Suzlon Energy soars 7%, trades at 7-month high; what's driving stock?

Business Standard

Suzlon Energy quoted higher for the third straight trading day, rallying 11 per cent to 59.25, its highest level since November 7, 2025.

Suzlon Energy has gained 39.87% in the last 3 Months

Suzlon Energy shares jump over 6%. Why brokerages call it India's most investible wind energy stock?

Economic Times | 16 Jun 2026, 11:10AM 4 more

Billionbrains Garage Ventures Ltd.

16 Jun 2026, 01:30PM

199.68

-3.69%

GIFT City clears way for Zerodha, Groww, Upstox to offer int'l investing

Business Standard

The international investing services are likely to launch in the next two to three months after brokers complete technology integration, testing and regulatory approvals

Number of MF schemes increased from 18 to 28 in Mar 2026 qtr.

Mankind Pharma Ltd.

16 Jun 2026, 12:00AM

2356.20

-1.01%

MANKIND PHARMA LIMITED

Accumulate: Mankind Pharma Ltd.

Recommendation Target

Geojit BNP Paribas

*over or under performance to benchmark index Mankind Pharma is a multinational pharmaceutical and healthcare product company, headquartered in Delhi. It manufactures products in therapeutic areas ranging from...

Mankind Pharma Ltd. is trading below its 30 day SMA of 2408.1

Suzlon Energy Ltd.

16 Jun 2026, 12:00AM

57.92

4.23%

SUZLON 2.0: Transforming into a Full-Stack Renewable Energy Platform

Not Rated: Suzlon Energy Ltd.

Deven Choksey

We attended the Suzlon 2.0 Analyst Meeting, where management outlined its strategy to transform Suzlon from a wind turbine OEM into a wind-first integrated renewable energy solutions provider supported by expansion into EPC, FDRE, hybrid projects, asset management, BESS and digital solutions.

Deven Choksey released a Not Rated report for Suzlon Energy Ltd. on 16 Jun, 2026.

Ashok Leyland Ltd.

15 Jun 2026, 11:54PM

158.50

0.51%

Ashok Leyland signs pact for old truck, bus replacement in Delhi-NCR

Business Standard

In addition to the 8 per cent discount offered by participating OEMs, the Central Government will provide 5 per cent interest subvention and fixed monthly fuel vouchers for a period of five years

Ashok Leyland has gained 35.01% in the last 1 Year

Ashok Leyland signs MoU for old truck and bus replacement scheme in Delhi-NCR, offers 8% discount

Business Line | 15 Jun 2026, 10:35PM

Waaree Energies Ltd.

15 Jun 2026, 11:09PM

3064.60

0.45%

Waaree Energies gets shareholders' nod to raise up to 10,000 cr via QIP

Business Standard

Waaree Energies on Monday said that it has got shareholders' approval to raise up to Rs 10,000 crore through the issuance of equity shares on a Qualified Institutions Placement basis. On April 29, the board of the company approved raising of up to Rs 10,000 crore through the issuance of equity shares, non-convertible debentures, along with warrants, any other eligible securities convertible into equity shares of the company, or any combination (collectively, securities) on Qualified Institutional Placement. According to a regulatory filing, the company got shareholders' approval to raise capital through a qualified institutions placement. The shareholders also approved the appointment of Jignesh Devchandbhai Rathod as a Whole-Time Director & CEO of the company. "...the resolutions as proposed in the postal ballot notice dated May 14, 2026, have been passed by the shareholders by remote e-voting process with requisite majority, on Saturday, June 13, 2026 (last date of remote...

Waaree Energies Ltd. has an average target of 3941.00 from 4 brokers.

Waaree Energies gets shareholders' nod to raise up to Rs 10,000 cr via QIP

Economic Times | 15 Jun 2026, 07:51PM

LG Electronics India Ltd.

15 Jun 2026, 08:18PM

1569.60

2.64%

India key growth engine for HVAC business, top market for residential air-conditioners: LG Electronics

Business Line

LG's third factory coming up in Sri City to service the southern India market as well as export markets

LG Electronics India.. has an average target of 1834.67 from 9 brokers.

India key growth engine for HVAC business, top market for residential air-conditioners: LG Electronics

Business Line | 15 Jun 2026, 06:45PM

ICICI Lombard General Insurance Company Ltd.

15 Jun 2026, 07:36PM

1783.60

2.85%

ICICI Lombard urges higher health cover citing rising healthcare costs

Business Standard

The insurer said customers should consider higher sums insured to keep pace with rising treatment costs, while stressing that the final decision rests with policyholders

ICICI Lombard Genera.. has an average target of 2190.00 from 3 brokers.

ICICI Lombard says E-20 fuel use won't affect motor insurance claims

Business Standard | 15 Jun 2026, 06:16PM 1 more

Is Nifty Midcap 100 worth buying?

169 Votes:

Buy 68.64%

Sell 18.34%

Hold 13.02%

Nifty Midcap 100 PB	4.8
Nifty Midcap 100 PE	29.7
Nifty Midcap 100 DIV	0.6
Nifty Midcap 100 EPS	2,084.4

Near 52W High of ₹62907.50

Nifty Midcap 100 PB

Nifty Midcap 100 PE

Nifty Midcap 100 DIV

Nifty Midcap 100 EPS

Nifty Midcap 100 News and Updates

Keep track of all breaking news on Nifty Midcap 100 from all sources in a single place.